Paper · 42840663
The Amyloid State of Mutant p53 in Cancer.
Iwahashi N and 1 other. JMA J, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Amyloid State of Mutant p53 in Cancer. Papers, record 42840663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42840663
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Amyloid State of Mutant p53 in Cancer.
- Journal
- JMA J
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-08
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,261,674 | Exosomes: endosomal-derived vesicles shipping extracellular messages. | Curr Opin Cell Biol | 2004 | https://conductscience.org/library/papers/15261674 | PubMed |
| 2 | 38,212,344 | Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38212344 | PubMed |
| 3 | 39,031,627 | Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma. | Cancer Sci | 2024 | https://conductscience.org/library/papers/39031627 | PubMed |
| 4 | 19,345,189 | A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. | Cell | 2009 | https://conductscience.org/library/papers/19345189 | PubMed |
| 5 | 40,410,530 | Detection of p53 aggregates in plasma of glioma patients. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/40410530 | PubMed |
| 6 | 22,869,710 | First-order rate-determining aggregation mechanism of p53 and its implications. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22869710 | PubMed |
| 7 | 11,238,924 | A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. | Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11238924 | PubMed |
| 8 | 40,657,305 | Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML. | Hemasphere | 2025 | https://conductscience.org/library/papers/40657305 | PubMed |
| 9 | 33,131,904 | Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer. | Gynecol Oncol | 2021 | https://conductscience.org/library/papers/33131904 | PubMed |
| 10 | 36,471,402 | p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations. | Diagn Pathol | 2022 | https://conductscience.org/library/papers/36471402 | PubMed |
1 to 10 of 63
See all 63 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42840663
GET https://conductscience.org/api/papers/v1/42840663/references?page=2